Journal • Tumor mutational burden • BRCA Biomarker • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • TMB (Tumor Mutational Burden) • BRCA1 (Breast cancer 1, early onset) • FGFR3 (Fibroblast growth factor receptor 3) • ATM (ATM serine/threonine kinase) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • ARID1A (AT-rich interaction domain 1A) • PALB2 (Partner and localizer of BRCA2) • RNF43 (Ring Finger Protein 43) • SMAD4 (SMAD family member 4) • GAS6 (Growth arrest specific 6) • MMP17 (Matrix Metallopeptidase 17) • WRN (WRN RecQ Like Helicase) • TENM4 (Teneurin Transmembrane Protein 4) • MMP7 (Matrix metallopeptidase 7) • USP7 (Ubiquitin Specific Peptidase 7)
|
PD-L1 expression • TP53 mutation • KRAS mutation • ATM mutation • PALB2 mutation • KRAS wild-type • RAS wild-type • SMAD4 mutation • FGFR3 fusion • WRN mutation